Frontiers in Oncology | Hematologic Malignancies

Review

Published on 08 Nov 2023

The implication of next-generation sequencing in the diagnosis and clinical management of non-Hodgkin lymphomas

in Hematologic Malignancies

Victor Tomacinschii
Adrian Mosquera Orgueira
Carlos Aliste Santos
Maria Robu
Sanda Buruiana
Maximo Francisco Fraga Rodriguez

Frontiers in Oncology

doi 10.3389/fonc.2023.1275327

7,268 views
1 citation

Original Research

Published on 08 Nov 2023

Transient TKI-resistant CD44+pBAD+ blasts undergo intrinsic homeostatic adaptation to promote the survival of acute myeloid leukemia in vitro

in Hematologic Malignancies

Yi Xu
David J. Baylink
Chien-Shing Chen
Laren Tan
Jeffrey Xiao
Brandon Park
Ismael Valladares
Mark E. Reeves
Huynh Cao

Frontiers in Oncology

doi 10.3389/fonc.2023.1286863

2,488 views
1 citation

Original Research

Published on 07 Nov 2023

Dynamic changes in physical function during intensive chemotherapy affect transplant outcomes in older adults with AML

in Hematologic Malignancies

Gi-June Min
Byung-Sik Cho
Daehun Kwag
Sung-Soo Park
Silvia Park
Jae-Ho Yoon
Sung-Eun Lee
Ki-Seong Eom
Yoo-Jin Kim
Seok Lee

Frontiers in Oncology

doi 10.3389/fonc.2023.1281782

1,874 views
1 citation

Editorial

Published on 07 Nov 2023

Editorial: Understanding leukemia biology using genome editing techniques

in Hematologic Malignancies

Silvia Jimenez-Morales
Kaushik Banerjee
Nirmalya Saha
Amrita Basu
Kathy L. McGraw

Frontiers in Oncology

doi 10.3389/fonc.2023.1323584

1,417 views

Review

Published on 07 Nov 2023

Refractory celiac disease and its mimickers: a review on pathogenesis, clinical-pathological features and therapeutic challenges

in Hematologic Malignancies

Federico Scarmozzino
Marco Pizzi
Filippo Pelizzaro
Valentina Angerilli
Angelo Paolo Dei Tos
Francesco Piazza
Edoardo Vincenzo Savarino
Fabiana Zingone
Matteo Fassan

Frontiers in Oncology

doi 10.3389/fonc.2023.1273305

5,774 views
8 citations

Original Research

Published on 07 Nov 2023

Poor outcome of pediatric B-cell acute lymphoblastic leukemia associated with high level of CRLF2 gene expression in distinct molecular subtypes

in Hematologic Malignancies

Danna Lin
Keyan Yang
Lihua Yu
Lulu Huang
Xiaorong Lai
Li Wu
Xiayu Xia
Jingwen Zhang
Qinlong Zheng
Lihua Yang

Frontiers in Oncology

doi 10.3389/fonc.2023.1256054

2,516 views
1 citation

Case Report

Published on 03 Nov 2023

Case report: Deep molecular remissions post two separate CD19-targeted chimeric antigen receptor T-cell therapies do not prevent disease from relapsing in Philadelphia chromosome-positive acute lymphoblastic leukemia

in Hematologic Malignancies

Yu Tang
Xiaoming Fei
Xianqiu Yu
Jiang Cao
Lixia Wang
Fang Lei

Frontiers in Oncology

doi 10.3389/fonc.2023.1251738

1,678 views

Original Research

Published on 02 Nov 2023

Integrated analysis of randomized controlled trials evaluating bortezomib + lenalidomide + dexamethasone or bortezomib + thalidomide + dexamethasone induction in transplant-eligible newly diagnosed multiple myeloma

in Hematologic Malignancies

Laura Rosiñol
Benjamin Hebraud
Albert Oriol
Anne-Laurène Colin
Rafael Ríos Tamayo
Cyrille Hulin
María Jesús Blanchard
Denis Caillot
Anna Sureda
Miguel Teodoro Hernández

Frontiers in Oncology

doi 10.3389/fonc.2023.1197340

3,756 views
11 citations

Case Report

Published on 01 Nov 2023

An adolescent with primary cutaneous follicle center lymphoma: a case report and literature review

in Hematologic Malignancies

Wen-Yan Niu
Xue-Shen Yan
Han Qiao
Yu-Jiao Sun
Hai-Yan Gu
Guang-Lun Li
Zhong-Guang Cui
Juan Du

Frontiers in Oncology

doi 10.3389/fonc.2023.1273719

1,555 views
2 citations

Case Report

Published on 01 Nov 2023

Case Report: A novel FGFR1 fusion in acute B-lymphoblastic leukemia identified by RNA sequencing

in Hematologic Malignancies

Zhibo Zhang
Yiyan Zhu
Zheng Wang
Zhao Zeng
Lijun Wen
Ling Zhang
Suning Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1276695

2,163 views
3 citations

Original Research

Published on 01 Nov 2023

Impact of different chemotherapy regimens on intestinal mucosal injury assessed with bedside ultrasound: a study in 213 AML patients

in Hematologic Malignancies

Edoardo Benedetti
Ginevra Traverso
Giulia Pucci
Riccardo Morganti
Emilia Bramanti
Piero Lippolis
Maria Chiara Susini
Elisa Mazzantini
Rachele Giubbolini
Fabrizio Mavilia

Frontiers in Oncology

doi 10.3389/fonc.2023.1272072

2,996 views
3 citations

Original Research

Published on 30 Oct 2023

Analysis of redox status and HDL subclasses in patients with lymphoma and the associations with FDG-PET/CT findings

in Hematologic Malignancies

Bosa Mirjanic-Azaric
Sinisa Stankovic
Lana Nezic
Zana Radic Savic
Dragana Malcic- Zanic
Ranko Skrbic
Jelena Kotur-Stevuljevic
Natasa Bogavac-Stanojevic

Frontiers in Oncology

doi 10.3389/fonc.2023.1221414

1,749 views
1 citation

Original Research

Published on 25 Oct 2023

Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170)

in Hematologic Malignancies

Ga-Young Song
Je-Jung Lee
Joon Ho Moon
Dajung Kim
Min Kyoung Kim
Hyo Jung Kim
Yeung-Chul Mun
Won-Sik Lee
Young Rok Do
Jae Hoon Lee

Frontiers in Oncology

doi 10.3389/fonc.2023.1209110

2,526 views

Original Research

Published on 25 Oct 2023

Exploring the cell-free total RNA transcriptome in diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma patients as biomarker source in blood plasma liquid biopsies

in Hematologic Malignancies

Philippe Decruyenaere
Edoardo Giuili
Kimberly Verniers
Jasper Anckaert
Katrien De Grove
Malaïka Van der Linden
Dries Deeren
Jo Van Dorpe
Fritz Offner
Jo Vandesompele

Frontiers in Oncology

doi 10.3389/fonc.2023.1221471

4,920 views
3 citations

Original Research

Published on 24 Oct 2023

The telomerase inhibitor imetelstat differentially targets JAK2V617F versus CALR mutant myeloproliferative neoplasm cells and inhibits JAK-STAT signaling

in Hematologic Malignancies

Kathrin Olschok
Bianca Altenburg
Marcelo A. S. de Toledo
Angela Maurer
Anne Abels
Fabian Beier
Deniz Gezer
Susanne Isfort
Katrin Paeschke
Tim H. Brümmendorf

Frontiers in Oncology

doi 10.3389/fonc.2023.1277453

6,009 views
11 citations

Original Research

Published on 24 Oct 2023

Management and clinical outcomes of follicular lymphoma across continuous lines of treatments: a retrospective analysis in China

in Hematologic Malignancies

Jiaxin Liu
Yunfei Hu
Linjun Zhao
Reyizha Nuersulitan
Yanfei Liu
Hui Yu
Yingying Ye
Dedao Wang
Yongjing Tang
Feier Feng

Frontiers in Oncology

doi 10.3389/fonc.2023.1264723

3,688 views
2 citations